Boxel et al. [38] showed that heartburn, abdominal discomfort, and nausea increased significantly during lipid infusion in GERD patients, and this finding is to be linked with an enhancement of chylomicron production and secretion that may stimulate release of cholecystokinin, an activator of vagal afferents. This evidence concerns the gene CCK and gastroesophageal reflux disease.